Exploration of dimensionality and psychometric properties of the Pittsburgh Sleep Quality Index in cases with temporomandibular disorders by Ksenija Rener-Sitar et al.
Rener-Sitar et al. Health and Quality of Life Outcomes 2014, 12:10
http://www.hqlo.com/content/12/1/10RESEARCH Open AccessExploration of dimensionality and psychometric
properties of the Pittsburgh Sleep Quality Index
in cases with temporomandibular disorders
Ksenija Rener-Sitar1,2,3*, Mike T John3, Dipankar Bandyopadhyay4, Michael J Howell5 and Eric L Schiffman3Abstract
Background: This study assessed the dimensional structure of sleep quality with the Pittsburgh Sleep Quality Index
(PSQI) and investigated its psychometric properties in cases with temporomandibular disorders (TMD).
Methods: A convenience sample of 609 TMD cases (age: 37.1 ± 13.1 yrs, 18–67 yrs, 85% female) of the multi-center
Validation Project meeting Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) and with
sufficient PSQI data were included in this study. To investigate PSQI scores’ dimensionality, exploratory factor
analysis was used. Factors were identified using the Scree plot. To investigate internal consistency, Cronbach’s
alpha was calculated. Analyses were separately performed for TMD cases with (N = 496) and TMD cases without
a pain-related diagnosis (N = 113).
Results: The mean PSQI score for all TMD cases was 7.1 ± 4.0 units, range: 0–19. The exploratory factor analysis
identified one factor for cases with at least one pain-related TMD diagnosis as well as one factor for cases with a
pain-free TMD diagnosis that explained 41% of the variance in cases with pain-related TMD and 37% in cases with
pain-free TMD. Internal consistency for PSQI scores was alpha of 0.75 in cases with pain-related TMD, alpha of 0.66
in cases with pain-free TMD and alpha = 0.75 for all TMD cases.
Conclusions: Sleep quality in TMD patients is a unidimensional construct and can therefore be represented by one
summary score; a finding that is in line with previous reports in TMD patients.
Keywords: Temporomandibular disorders, Sleep disorders, Factor analysis, Psychometrics, Reliability and validity,
Orofacial pain, Chronic pain, Self-assessment, Questionnaires, Quality of lifeBackground
Temporomandibular disorders (TMD) are the umbrella
term encompassing mostly chronic pain conditions in-
volving the masticatory muscles, temporomandibular joint
(TMJ) an associated structures. More than half of the pa-
tients with chronic pain conditions report poor sleep qual-
ity [1]. Studies show that disruption of sleep exacerbates
pain and, conversely, pain contributes to sleep disturbance
[1]. Therefore, impaired sleep quality can contribute sub-
stantially to the suffering of chronic pain patients because* Correspondence: ksenija.rener@mf.uni-lj.si
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reproduction in any medium, provided the orthe sleep disorders are associated with significant quality
of life impairments. Patients with TMD pain are no excep-
tion. They frequently suffer from chronic orofacial pain
and also have comorbid sleep disorders [2]. They com-
monly report poor SQ (up to 90%) [2]. Since sleep distur-
bances have been associated with poor treatment
outcomes in the TMD patients [3], the assessment of sleep
quality needs to be a part of the comprehensive evaluation
of this patient population.
Subjective sleep assessment is challenging and ideally
provides data on at least four characteristics of sleep:
sleep initiation, sleep maintenance, sleep adequacy, and
daytime somnolence. Whereas polysomnography is an
objective measure of biophysiological sleep parameters,
sleep quality is usually assessed using self-report. There
are a number of patient-reported outcome instrumentstral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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these instruments assess the four sleep characteristics
noted above: Basic Nordic Sleep Questionnaire, Leeds
Sleep Evaluation Questionnaire, Medical Outcomes Study
Sleep Scale, Pittsburgh Sleep Diary, Sleep Dissatisfaction
Questionnaire, Self-Rated Sleep Questionnaire, and the
Pittsburgh Sleep Quality Index (PSQI) [4].
Since the introduction of the PSQI in 1989 by Buysse
et al. [5] to measure sleep quality among adult psychiatric
patients, this instrument has been employed in numerous
other patient populations including cancer, traumatic
brain injury and chronic pain patients in over 2,200 pub-
lished studies. The PSQI is composed of 19 items, which
are combined into seven components that are summa-
rized into a global score that represents a unidimensional
sleep quality construct [5]. However, five recent studies
[6-10] have questioned the appropriateness of using only
the global score. In 2006, Cole et al. examined PSQI
structure by exploratory and confirmatory factor analysis
in healthy and depressed elderly adults and showed initial
evidence that a single global PSQI score did not capture
the multidimensional nature of sleep disturbances when
examined by PSQI [6]. Subsequently, four other studies
explored the dimensionality of the PSQI and reported that
a two- and three- factor scoring model for the PSQI were
better to assess sleep quality compared to the originally
proposed single-factor model (Table 1) [5].
In a sample of Nigerian university students, a three-
factor model of the PSQI was identified [7], but the factors
differed from Cole’s et al. study making comparisons diffi-
cult. A study assessing sleep quality in Australian adults
also suggested two- and three-factor scoring models [8].
A three-factor model of the PSQI was also found to haveTable 1 Published studies investigating two- or three- factor
with samples description
Study Sample N N of
Cole et al. [6] USA community-dwelling depressed
and nondepressed adults > 60 years
417 Three
Aloba et al. [7] Nigerian university students 520 Three
Magee et al. [8] Australian adults aged 18 to 59 years 364 Two-
three-
Burkhalter et al. [9] Swiss renal transplant recipients 135 Three
Mariman et al. [10] Belgian chronic fatigue syndrome
patients
413 Three
The individual study’s suggested PSQI dimensions labels are written in italic and bo
dimension are listed in parentheses after each dimension label.a better fit in a sample of renal transplant recipients [9] as
well as in a sample of chronic fatigue syndrome patients
[10]. Cole et al. found that the PSQI factor structure has
three separate factors, that is, dimensions of sleep efficiency,
perceived sleep quality, and daily disturbances and these
are reported as 3 separate scores [6].
While both two-factor and three-factor models have
been reported, studies which assessed self-reported sleep
disturbances of the TMD patients used a global PSQI
score [2,11-14]. These findings indicate that the factor
structure of this instrument in TMD patients needs to be
further investigated. In particular, it is uncertain how
many PSQI scores are needed to characterize sleep quality
in this patient population. Moreover, the psychometric
properties of the PSQI used in TMD studies are also
unknown. This is important because the use of an instru-
ment in a specific patient population is justified only if
these properties are known.
The aim of this study was to assess the dimensionality
and the psychometric properties of reliability and valid-
ity for the PSQI in cases with pain-related TMD and in
cases with pain-free TMD.
Methods
Subjects
This study is a secondary data analysis, selecting from the
614 TMD cases of the multi-center RDC/TMD Validation
Project [15] the 609 TMD cases with at least one RDC/
TMD diagnosis [16] and a maximum of one missing PSQI
question. To classify TMD cases, the RDC/TMD protocol
provides criteria for classifying patients into pain-related
TMD and pain-free TMD. Pain-related diagnoses include
myofascial pain, temporomandibular joint (TMJ) arthralgiascoring models for the Pittsburgh Sleep Quality Index
factors Dimensions labels
-factor Sleep Efficiency (sleep duration, habitual sleep efficiency)
Perceived Sleep Quality (subjective sleep quality, sleep latency,
use of sleep medication)
Daily Disturbances (sleep disturbances, daytime dysfunction)
-factor First factor (subjective sleep quality, sleep latency, habitual sleep
efficiency, sleep disturbances, use of sleep medication)
Second factor (sleep duration and sleep disturbances)
Third factor (subjective sleep quality, habitual sleep efficiency,
use of sleep medication)
and
factor
Same factors as Cole et al. for the three- and without Daily
Disturbances for the two-factor model
-factor Same factors as Cole et al. [6]
-factor Same factors as Cole et al. [6]
ld text and the original PSQI components belonging to each suggested
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throsis and disc displacements, the latter with and
without pain. The RDC/TMD is the most commonly
used taxonomic classification system and use of it allows
comparison with other TMD studies [15].
Cases represented a convenience sample that was
recruited from both clinic and community sources (85%
female, age: 37.1 ± 13.1 years). Details of the study cases
and the settings have been previously reported [15]. Insti-
tutional review board's ethic approval was obtained at each
of the three study sites (the University of Minnesota, the
University of Washington, and the University at Buffalo)
prior to initiating the RDC/TMD Validation Project [15].
The study sample of 609 TMD cases was further
divided into two groups according to the presence or
absence of at least one RDC/TMD pain-related diagno-
sis. The 496 pain-related TMD cases had at least one
RDC/TMD diagnosis of myofascial pain and/or arth-
ralgia and/or osteoarthritis. The second group of 113
TMD cases had RDC/TMD diagnosis of pain-free TMJ
disc displacement and/or osteoarthrosis.
A subset of the RDC validation study cases [15] (N = 64)
had retest PSQI data that were collected two weeks after
the baseline examination. This interval was chosen as data
from other oral health self-report instruments suggest that
perceived oral health does not influence reporting substan-
tially over short periods of repeated assessment [17,18].Pittsburgh Sleep Quality Index (PSQI) instrument
The PSQI is composed of 19 self-rated questions (items)
and 5 questions rated by a bed partner or roommate
pertaining to sleep disturbances. Only the self-rated
items are used in scoring the overall scale. The self-
administered scale contains 15 multiple-choice items
that inquire about frequency of sleep disturbances and
subjective sleep quality during the previous month.
Four additional write-in items inquire about typical
bedtime, wake-up time, sleep latency, and sleep dur-
ation. The 5 bed partner questions are multiple-choice
ratings of sleep disturbance and are used for clinical
information only. The 19 self-rated PSQI items are
combined into seven components: subjective sleep
quality, sleep latency, sleep duration, habitual sleep
efficiency, sleep disturbances, use of sleep medications,
and daytime dysfunction. Each component has a score
that ranges from 0 (no difficulty) to 3 (severe diffi-
culty). All component scores are summed to produce a
global score ranging from 0–21. According to the
authors of the PSQI instrument, a PSQI global score
greater than 5 is suggestive of significant sleep disturb-
ance [5]. Most patients need 5–10 minutes to complete
the PSQI questionnaire. No formal training is needed
to administer and score this scale [19].Data analysis
Item analysis of PSQI components
An item analysis was performed according to a previously
published protocol [20]. Means, standard deviations, and
the proportions of the zero values were computed for each
PSQI component, as well as for the global PSQI score,
separately for cases with pain-related TMD and cases with
pain-free TMD.
Inspection of correlations among the PSQI components
The central characteristic of a construct is that its indica-
tors co-vary with each other. To detect patterns among
correlations indicating possible dimensions among the
components scores, we inspected the polychoric correl-
ation matrix of the PSQI component scores separately for
both cases with pain-related TMD and cases with pain-
free TMD [21].
Factor-analytic methods
The PSQI components were submitted to exploratory
factor analysis. Factors were extracted using the principal
factors method. The Scree plot method according to
Cattell [22] was used to indicate the number of factors to
be extracted. If more than one factor would be extracted,
factors would be rotated using the orthogonal varimax or
oblique promax technique. Item loadings were examined
and values larger than 0.50 were considered indicative of
a relationship between the item and the associated under-
lying factor [23].
To assess model fit, we also performed a confirma-
tory factor analysis. Because data may violate the nor-
mality assumption, we used diagonally weighted least
squares (DWLS) [24] and a “robust” method using the
Huber-White sandwich estimator [25]. Model fit was
assessed using the log-likelihood chi-square test, the
standardized root mean square residual (SRMR), the
root mean square error of approximation (RMSEA),
the comparative fit index (CFI), and the Tucker–Lewis
index (TLI). Commonly applied guidelines for adequate
model fit suggest: SRMR: ≤0.08; RMSEA: ≤0.06; and CFI,
TLI: ≥0.95 [26].
In addition to the assessment of dimensionality in
the subgroups of cases with pain-related TMD and
cases with pain-free TMD, we also performed separate




Cronbach’s alpha [27] and average inter-item correlation
for the Pearson correlation coefficients were computed as
measures of the scores’ internal consistency. Both mea-
sures are indicators of the items’ homogeneity and indi-
cate how strongly the items are correlated. The values of
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According to Clark and Watson [29], mean inter-item
correlation should fall within the range of 0.15 to 0.20
for scales that measure broad characteristics and
within the range of 0.40 to 0.50 for those measuring
narrower ones.
Test-retest reliability
Temporal stability of the scores was investigated in a
subset of cases from the RDC/TMD Validation Project
cases with test-retest data [15]. To characterize test-
retest reliability, intraclass correlation coefficients (ICC)
were calculated using a one-way repeated measure
ANOVA, treating the cases as a random factor. Reliabil-
ity was assessed for both the instrument’s summary
score and the seven PSQI components. Calculations
were performed according to Shrout & Fleiss’s ICC
type 2,1 [30]. Furthermore, the method of Bland and
Altman [31] was used to compute the standard devi-
ation of the differences between the first and second
time points. “Limits of agreement” around the mean dif-
ference were calculated as 1.96 times the standard devi-
ation of the differences. Hence, this statistic represents
the test-retest differences expected for 95% of the indi-
viduals in the sample. If the confidence interval for the
mean of the differences excluded zero, it indicated a sta-
tistically significant difference between the measures.
Score validity
Two questions that are related to sleep from the General
Health Questionnaire (GHQ) [32] were used to assess
convergent validity. The questions “Have you recently lost
much sleep over worry?” and “Have you recently had diffi-
culty staying asleep?” are rated from 0 to 3 on the
four-points ordinal scale, where 0 means “Not at all”, 1 –
“No more than usual”, 2 – “Rather more than usual”, and
3 – “Much more than usual”. The Spearman’s rho coeffi-
cient, a nonparametric measure of statistical dependenceTable 2 Descriptive statistics for the seven PSQI components






1. Subjective sleep quality [0–3] 1.2 (0.8)
2. Sleep latency [0–3] 1.2 (1.0)
3. Sleep duration [0–3] 0.6 (0.9)
4. Habitual sleep efficiency [0–3] 1.3 (1.3)
5. Sleep disturbances [0–3] 1.5 (0.6)
6. Use of sleep medication [0–3] 0.7 (1.1)
7. Daytime dysfunction [0–3] 1.0 (0.7)
PSQI global score [0–21] 7.1 (4.0)between two quantities, was used to assess the correl-
ation between each question and the PSQI scores.
The correlation between these two items and the PSQI
score was expected to be “medium” according to guide-
lines [33].
Missing data and statistical software
Five of the 614 TMD cases had more than one missing
PSQI item and were therefore not included in the
analysis. Two hundred and thirty four cases had one
missing value, which were consequently imputed using a
robust median imputation within the particular PSQI
item. Analyses were performed using the statistical
software package STATA, (Stata Statistical Software:
Release 12. College Station, TX: StataCorp LP). Any
result was considered statistically significant if P < 0.05.
Results
Item analysis
The mean PSQI global score for all 609 TMD cases was
7.0. For the cases with pain-related TMD, the mean
values for all of the seven PSQI components were higher
in comparison to pain-free TMD cases (Table 2). The
PSQI component that was most impaired was sleep
disturbances with a mean of 1.5 in cases with pain-
related TMD and 1.1 in cases with pain-free TMD. The
least impaired PSQI component or the lowest score was
reported for sleep duration in the cases with pain-
related TMD (0.6 ± 0.9) and use of sleep medication in
the cases with pain-free TMD (0.2 ± 0.7) indicating the
latter cases used less sleep medication. Floor effects
were observed frequently for all the PSQI components
except for sleep disturbances.
Inspection of the polychoric correlation matrix
The polychoric correlation matrix (Table 3) presented
varying correlations between the seven PSQI compo-
nents, ranging from −0.18 to the low 0.70 s. In casesand the PSQI global score (bold text) shown separately
ted TMD Cases with pain-free TMD
(N = 113)
% of 0 values Mean (SD) % of 0 values
17.3 0.8 (0.7) 31.9
29.0 0.8 (0.8) 45.1
58.9 0.5 (0.7) 61.1
44.8 1.0 (1.4) 61.1
2.2 1.1 (0.4) 1.8
65.1 0.2 (0.7) 86.7
23.4 0.6 (0.6) 49.6
0.4 5.1 (3.1) 0.0
Table 3 Polychoric correlation matrices for the seven
PSQI components in cases with pain-related TMD and
cases with pain-free TMD are shown in the lower left
triangle area, and the upper right triangle area,
respectively
PSQI component 1. 2. 3. 4. 5. 6. 7.
1. Subjective sleep quality 0.54 0.55 0.26 0.74 0.06 0.54
2. Sleep latency 0.57 0.39 0.32 0.53 0.35 0.33
3. Sleep duration 0.58 0.46 0.26 0.28 0.01 0.34
4. Habitual sleep efficiency 0.33 0.36 0.51 0.26 −0.18 0.23
5. Sleep disturbances 0.64 0.47 0.45 0.17 −0.12 0.58
6. Use of sleep medication 0.32 0.36 0.30 0.12 0.39 −0.07
7. Daytime dysfunction 0.39 0.28 0.32 0.14 0.42 0.31
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0.64. The average inter-item correlation was 0.30 in this
group of cases. In cases with pain-free TMD, the correla-
tions ranged from −0.18 to 0.74, and among them, three
correlations had a negative value, although all three of
them were of small magnitude. The average inter-item
correlation was smaller in comparison to the cases with
pain-related TMD with a value 0.22.
Factor-analytic methods
The exploratory factor analysis identified one factor for the
pain-related TMD cases as well as for the pain-free TMD
cases (Table 4). The factors explained 41% of the variance
in the cases with pain-related TMD and 37% in the cases
with pain-free TMD. Scree plots of eigenvalues plotted
against the factor numbers after exploratory factor analysis
are shown in Figure 1. In our confirmatory factor analysis
for all TMD cases using DWLS, the unidimensional modelTable 4 One-factor model resulting from the exploratory
factor analysis from the unrotated factor structure matrix
for the seven PSQI components derived separately from
cases with pain-related TMD (N = 496), cases with













2. Sleep latency 0.74 0.73 0.75












0.58 0.71 0.62fit the data well. The chi-square test (χ2 (14) = 32.746,
p = 0.003) rejected the model, as we expected with our
large sample size. The RMSEA was 0.05, the SRMR was
0.04, and CFI and TLI were greater than 0.95. Using the ro-
bust method for estimation, model fit worsened. The chi-
square test (χ2 (14) = 66.235, p < 0.001) rejected the model
as well, RMSEA was 0.08, SRMR was 0.04, CFI was 0.93,
and TLI was 0.90. When the fit indices were compared
to guideline values, all indices using DWLS estimation
exceeded recommendations. For robust estimation, one
index (SRMR) exceeded recommendations and four indices
did not. When we performed subgroup analyses for pain-
related and pain-free TMD cases as well as for women and
men, model fit results showed a similar pattern in all sub-
groups compared with the total sample except for the pain-
free TMD cases. Here, both DWLS and robust methods
exceeded all guidelines values for model fit, providing
strong support for the unidimensional model.
Reliability
Test-retest reliability characterized by the intraclass correl-
ation coefficients (ICCs) was calculated for the seven PSQI
components (Table 5). The median ICC for the seven PSQI
components was 0.86 (range 0.57-0.91). Means of the
differences between the two administrations of the ques-
tionnaire were small, ranging from −0.08 to 0.09 and were
all statistically not significant. Limits of agreement indicat-
ing the interval for 95% of the test–retest differences were
similar across the components and were all in the range
of −1.28 to 1.36 except for the component habitual sleep
efficiency, where the limits of agreement were larger with a
range of −2.50 to 2.35.
Internal consistency of a PSQI was computed separ-
ately for the cases with pain-related TMD, the cases
with pain-free TMD and also for the TMD cases with
test-retest data. The Cronbach’s alpha value (including
the one-sided confidence interval) and the average
inter-item correlation were 0.75 (0.72) and 0.30 for the
cases with pain-related TMD. For the cases with pain-
free TMD, these values were 0.66 (0.58) and 0.22. For
cases with test-retest data, values were 0.70 (0.63) and
0.25. The Cronbach’s alpha calculations with one of the
seven components from the PSQI missing were also
performed. When the sixth component use of sleep
medication of the cases with pain-free TMD was omit-
ted, the alpha value increased from 0.66 to 0.73.
Validity
The pattern of increasing PSQI means with increasing
levels of the validation questions supported PSQI sum-
mary score convergent validity (Table 6). For both global
questions, similar trends were observed. As expected,
the rank correlation coefficients were statistically signifi-
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Figure 1 Scree plots of eigenvalues after exploratory factor analysis are shown separately for cases with pain-related TMD, cases with
pain-free TMD, and for all TMD cases.
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The current study demonstrated that sleep quality in TMD
patients, as assessed by the PSQI, is a unidimensional
scoring structure. When the PSQI data for TMD cases with
or without painful diagnose were analyzed separately with
exploratory factor analysis and the inspection of the scree
plots, the results showed clearly a single common latent
factor that explained item responses. The only exception
was a low loading for the sixth component of the PSQI
questionnaire called use of sleep medication for the cases
with pain-free TMD. These individuals don’t use a lot of
sleep medications, and therefore, sleep disturbances due to
sleep medications are challenging to identify. Internal
consistency of the PSQI was also lower in these latter cases
with Cronbach’s alpha value of 0.66, which was below the
threshold for the internal consistency. When the use of
sleep medication data was omitted from the analysis, the
internal consistency coefficient increased to 0.73. Sleep






Subjective sleep quality 0.76 (0.66 to 0.86) −0.0
Sleep latency 0.77 (0.68 to 0.87) 0.09
Sleep duration 0.73 (0.62 to 0.84) 0.03
Habitual sleep efficiency 0.57 (0.40 to 0.73) −0.0
Sleep disturbances 0.69 (0.57 to 0.82) 0.05
Use of sleep medication 0.91 (0.87 to 0.95) 0.09
Daytime dysfunction 0.60 (0.44 to 0.75) 0.00
PSQI global score 0.86 (0.80 to 0.92) 0.12a strong relationship with the other variables. However,
greater use of sleep medications by cases with pain-related
TMD may mitigate differences in sleep quality, if the medi-
cations are effective, compared to pain-free TMD cases
thus masking the true difference between these two types
of cases. Conversely, cases with pain-related TMD may use
more sleep medications because they use more medica-
tions in general, including pain medications, and since they
see more doctors for their pain, they have more opportun-
ity to get sleep medications.
The polychoric correlations between the subjective sleep
quality and the sleep disturbances, between the subjective
sleep quality and the sleep duration, and between the
subjective sleep quality and the sleep latency had the largest
magnitudes (up to 0.74). These large correlations were
similar in cases with pain-related TMD and in cases with
pain-free TMD.
The PSQI questionnaire comprises 19 individual items







6 (−0.19 to 0.07) −1.12 to 1.00 0.775
(−0.06 to 0.25) −1.18 to 1.36 0.740
(−0.12 to 0.18) −1.15 to 1.21 0.214
8 (−0.38 to 0.22) −2.50 to 2.35 0.535
(−0.07 to 0.17) −0.92 to 1.02 0.992
(−0.03 to 0.22) −0.90 to 1.08 0.358
(−0.16 to 0.16) −1.28 to 1.28 0.356
(−0.37 to 0.62) −3.83 to 4.08 0.679
Table 6 Convergent validity as assessed by correlations between two questions related to sleep from the General
Health Questionnaire (GHQ) and the Pittsburgh Sleep Quality Index (PSQI) for the TMD cases sample (N = 609)




Spearman’s rho (95% CI),
and a level of significance
Have you recently lost much sleep over worry? 0.43 (0.36 to 0.49)*
Not at all 296 5.4 3.4
No more than usual 239 8.1 3.8
Rather more than usual 63 9.6 4.0
Much more than usual 11 12.5 2.7
Have you recently had difficulty in staying asleep? 0.48 (0.42 to 0.54)*
Not at all 288 5.1 2.8
No more than usual 211 7.9 3.9
Rather more than usual 94 10.1 4.1
Much more than usual 16 11.8 2.9
*P < 0.001.
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components is performed differently than most multi-item
self-report instruments which use simple sum of their
items (i.e. Oral Health Impact Profile questionnaire) [34]. A
particular computation is needed for each of the seven
PSQI components. This burden may potentially obscure
the meaning of each component and also impede a wide-
spread clinical application.
Our results can be generalized to other TMD populations
because the RDC/TMD Validation Project data set was
derived from a diverse spectrum of TMD clinic and commu-
nity cases [15]. All participants were thoroughly evaluated to
ensure correct TMD diagnosis necessary for inclusion as
study cases [15]. Even among TMD patient populations with
different distributions of TMD diagnostic subtypes, such dis-
crepancies would not limit generalizability, because we have
demonstrated that the dimensional structure of the PSQI is
not substantially different between the cases with pain-
related TMD and cases with pain-free TMD which is a major
classification used in TMD clinical practice and research.
We found nine studies using the PSQI instrument in
TMD patients [2,11,12,14,35-39]. All of these studies
reported sleep quality as being one dimension repre-
sented by one global PSQI score. Some of these studies
reported only a global PSQI score and defined poor
sleep quality as the global PSQI score being larger than
5 [35,38,39]. However, Yatani et al. [2] used the median
cutoff of a global PSQI score ≥ 10 to divide “good” and
“poor sleepers”. The six remaining studies reported
results for some [14,37] or for all seven PSQI subscores
[11-13,36], but none of these studies reported correla-
tions among the seven components. Thus, this is the
first study to report correlations between PSQI subscores
in TMD patient population. Besides reporting a global
PSQI score for TMD patients, Abrahamsen et al. [37] listed
also the average answers obtained from the individual ques-
tions contained in the PSQI questionnaire, e.g. Hours ofsleep, Minutes before falling asleep, Number of awaken-
ings, Number of awakenings due to pain, and Episodes
of daytime sleep.
We did not find any other multiple-item instrument
that has been used to assess sleep quality in the TMD
patients. Although some studies have used single–item
questionnaires to assess sleep quality, multi-item instru-
ments have advantages in terms of validity and reliability
compared to a single question. Therefore, there is a limit
to how brief an instrument can be, and in part, depends on
whether it is intended for clinical or research purposes. Al-
though the causation is currently unknown [40], sleep
quality is an important issue for successful management of
TMD patients. Finally, a briefer version of the PSQI and
simplification of its computation would probably popular-
ize its clinical utility significantly.
Our study had some limitations. More than one third
of our TMD patient population had one missing value
in the PSQI questionnaire. The results were probably
not affected substantially, because the unidimensional
construct of PSQI is characterized with 15 items. For
all the subjects in the analyses we had at least 14 items.
It is highly unlikely that this situation may have pre-
vented the detection of a second factor – the major al-
ternative for a unidimensional model. We divided all
the TMD diagnoses only in two categories, the pain-
related TMD and pain-free TMD. The pain-related
TMD diagnoses comprised a myofascial pain as well as
TMJ pain, which have different clinical characteristics.
When we assessed model fit for our dimensionality
results not all findings agreed. All results of the ex-
ploratory factor analysis favored unidimensionality, but
some indices for the confirmatory factor analysis came
only close to guideline recommendations. One reason
for this situation might be that our TMD cases only
used sleep medication rarely and this item had the low-
est correlation with the latent factor and consequently a
Rener-Sitar et al. Health and Quality of Life Outcomes 2014, 12:10 Page 8 of 9
http://www.hqlo.com/content/12/1/10decreased model fit. Furthermore, a convenience sampling
methodology was used. Nevertheless, the psychometric
properties of the PSQI were assessed in TMD patients for
the first time, and dimensionality of the PSQI was graphic-
ally assessed also by the use of scree plots and two factor-
analytic methods. While the majority of our methods
agreed that sleep disturbances in TMD patients can be
characterized with one score and we have explored dimen-
sionality in subgroups, more sophisticated analyses of
measurement invariance [41] across populations are a next
step in a rigorous assessment of psychometric properties.
We used a convenience sample which is inferior to a con-
secutive sample, but our sample size was large and our pa-
tients covered the entire spectrum of TMD patients.
In conclusion, although the PSQI instrument was ini-
tially developed for psychiatric practice and research,
our study provides additional evidence that it has good
psychometric properties and excellent comparability of
score results with other published studies for different
patient populations. For the TMD patient population,
the results obtained from the PSQI questionnaire can
continue to be reported in the form of one global score.
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